E
Everest Medicines Ltd
HKEX:1952
Everest Medicines Ltd
HKEX:1952
Price:
35.26
HKD
8.36%
Market Closed
Market Cap:
HK$12.5B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
E
|
Everest Medicines Ltd
HKEX:1952
|
CN |
|
Jiangsu Eazytec Co Ltd
SSE:688258
|
CN |
|
D
|
DevEx Resources Ltd
OTC:UREQF
|
AU |
|
K
|
Kiler Holding AS
IST:KLRHO.E
|
TR |
|
Siebert Financial Corp
NASDAQ:SIEB
|
US |
|
S
|
Shop Apotheke Europe NV
XETRA:SAE
|
NL |
|
X
|
Xiamen R&T Plumbing Technology Co Ltd
SZSE:002790
|
CN |
|
System1 Group PLC
LSE:SYS1
|
UK |
|
S
|
Shandong Tengda Fasten Tech Co Ltd
SZSE:001379
|
CN |
|
ImageOne Co Ltd
TSE:2667
|
JP |
|
Umicore SA
OTC:UMICY
|
BE |
|
Alzamend Neuro Inc
NASDAQ:ALZN
|
US |
|
Dubber Corp Ltd
ASX:DUB
|
AU |
|
Squarespace Inc
NYSE:SQSP
|
US |
|
C
|
Canada Goose Holdings Inc
SWB:1GC
|
CA |
|
Allison Transmission Holdings Inc
NYSE:ALSN
|
US |
|
Aluminum Corporation of China Ltd
SSE:601600
|
CN |
|
J
|
Jiangxi Synergy Pharmaceutical Co Ltd
SZSE:300636
|
CN |
|
T
|
Tata Steel Thailand PCL
SET:TSTH
|
TH |
|
PP Properti Tbk PT
IDX:PPRO
|
ID |
|
Doshisha Co Ltd
TSE:7483
|
JP |
|
Asia Pile Holdings Corp
TSE:5288
|
JP |
|
J
|
JRC Co Ltd
TSE:6224
|
JP |
Relative Value
The Relative Value of one Everest Medicines Ltd stock under the Base Case scenario is hidden HKD. Compared to the current market price of 35.26 HKD, Everest Medicines Ltd is hidden .
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
Everest Medicines Ltd Relative Value
HIDDEN
Multiples Across Competitors
Competitors Multiples
Everest Medicines Ltd Competitors
Everest Medicines Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CN |
E
|
Everest Medicines Ltd
HKEX:1952
|
11.3B HKD | 11.7 | -15.1 | -14.6 | -11.5 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 690 872.8 | -160 127.7 | -194 446.1 | -192 227.3 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
366.3B USD | 6 | 87.5 | 14.5 | 20.2 | |
| US |
|
Exact Sciences Corp
NASDAQ:EXAS
|
355.9B USD | 109.6 | -1 710.6 | 15 890.6 | -1 794.3 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
190.8B USD | 5.2 | 24.7 | 14.3 | 14.3 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
171.6B USD | 5.8 | 20.2 | 12.6 | 15.6 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
115.6B USD | 9.6 | 29.2 | 22 | 23 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 091 | -533.6 | -581 | -565.5 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
79.2B USD | 5.5 | 17.6 | 13 | 14.9 | |
| AU |
|
CSL Ltd
ASX:CSL
|
68B AUD | 3.1 | 34.7 | 11.5 | 14.4 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.1 | -61.8 | -66.6 | -60.1 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
